PlasmaShield's accreditation and
certification is to the highest
national and global standards.
Independent testing has confirmed PlasmaShield® produces no harmful gases or by-products,
while achieving up to 7-Log reduction in airborne microbial contamination.
Resources
Controlled Studies and Publications
Relative Health Risk Reduction from an Advanced Multi-Modal Air Purification System: Evaluation in a Post-Surgical Healthcare Setting, https://www.mdpi.com/1660-4601/21/8/1089
Efficacy of the PlasmaShield®, a Non-Thermal, Plasma-Based Air Purification Device, in Removing Airborne Microorganisms, https://www.mdpi.com/2673-3293/3/2/19
Diagnostics of Air Purification Plasma Device by Spatially Resolved Emission Spectroscopy, https://www.mdpi.com/2571-6182/5/2/16
Two‐dimensional Imaging of Excited N2 Molecules Produced in an Air Purification Device, https://link.springer.com/article/10.1007/s12650-022-00895-y
Evaluation of the PlasmaShield® air purification system for mitigation of volatile organic compounds, airborne particles, nitrogen dioxide and ozone emissions, https://doi.org/10.25909/6299f17f885fc
Airborne particulate matter filtration utilising non-thermal plasma air purification, https://www.ashrae.org/technical-resources/ashrae-journal
Air purification for indoor environments, what do comparative data for free standing and fixed systems tell us about effectiveness for risk management, AIOH 39th Annual Conference, Brisbane, December 2022 (ISBN 978-0-646-86879-0), https://www.aioh.org.au/product/simple-sustainable-solutions-_2022/
Independent Case Studies,
Reports and Whitepapers
- Methods of Air Decontamination. Review and Analysis of a novel medical Device, Flinders University.
- Potential of the Plasma Shield System in Reducing Energy and in Contributing Towards Green Buildings, University of South Australia.
- Investigation into the Energy Saving Potential of the Filter-Less Plasma Shield Technology, University of South Australia
- Evaluation of PlasmaShield Non-Thermal Plasma Air Purification and Disinfection System with Common Air Contaminants, University of Adelaide
- Viricidal efficacy of PlasmaShield against Human Coronavirus 229E, Flinders University
- Evaluation of resuscitation of viable (VBNC) Escherichia coli, Flinders University
Contact PlasmaShield
for access to our case studies & reports
Certification and Compliance
ISO 13485 Medical Device manufacturer company Certificate: MD 734288
Device Accreditations
- Australia TGA Class I listed medical device
- European CE, Class I Medical Device
- USA CARB Certificate
- ETL mark – for USA and Canada
Product Certification and Compliance
CB certified to all applicable Medical Devices’ standards
- ISO 14971,
- IEC 60601-1,
- IEC 60601-1-2,
- IEC 60601-1-6,
- IEC 62366
- UL 867 – Sec 40
- UL 2998
- EN 62311
- EN 301489-1
- EN 301489-17
- EN 300328,
- ISTA 3A,
- ANSI C63.27
Zero Ozone Emission certified product
